Fundz

Curavit Raises $5 Million In Series A Funding To Accelerate Growth In Digital Therapeutics Clinical Research

PRIVATENov 14, 2022

Amount Raised

$5 Million

Round Type

Series A

ScarsdaleBiotechnologyHealthcareHealth CareTherapeutics

Description

Curavit Clinical Research, a virtual contract research organization (VCRO) that specializes in decentralized clinical trials (DCTs), today announced it raised $5 million in Series A funding to accelerate its growing portfolio of research in the global digital therapeutics (DTx) market (projected to grow at a CAGR of 31.4% through 2026). The new funding will be used to expand the company's DCT capabilities, partnerships, and market adoption of Curavit's virtual CRO services and platform for prescription and non-prescription digital therapeutics trials.

Who else raised in Healthcare and Therapeutics around the same time

Companies in the same sectors as Curavit Clinical Research that raised within 45 days of this round, from Fundz verified event records.

  • Madrigal Pharmaceuticals raised $300M (Funding Round) on December 21, 2022.
  • QurAlis raised $60M on December 20, 2022.
  • BehaVR raised an undisclosed amount (Series B) on December 13, 2022.
  • NewcelX raised $10M on December 13, 2022.
  • Solid Biosciences raised $9.2M on December 2, 2022.
  • Parabilis Medicines raised $178M (Series D) on November 21, 2022.

Who to call at Curavit Clinical Research, and when

A new round usually means Curavit Clinical Research is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Curavit Clinical Research raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Curavit Clinical Research, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Curavit Clinical Research. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Curavit Clinical Research

Location

18 LARCH LANE

Scarsdale, New York, United States

About

Curavit, the “First All-Virtual CRO", designs and executes decentralized - or “virtual” - clinical trials. Curavit leverages emerging technologies in digital health, cloud computing, and data science to recruit, engage, and monitor diverse patient populations from wherever they live, work, or study; eliminating the need for physical infrastructure and travel, while increasing data quality. Curavit brings together the world’s leading researchers, enrolls previously untapped and underserved patient populations, applies machine learning algorithms to health and social engagement information to recruit participants, and leverages leading telehealth, patient data, and medical device technologies. Curavit’s central virtual site supports remote monitoring and is always audit ready.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Curavit Clinical Research raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsJoel M., CEO & Co-Founder hidden hidden hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Curavit Clinical Research's next move

See what Strategic adds

Funding Insights

What this usually means
Typical timeline to Series B
Series A companies typically raise their next round in 10-18 months

Curavit Clinical Research raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.